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Abstract: A series of [Cu(PˆP)(NˆN)][PF6] compounds are reported in which NˆN is 2,9-dibromo-1,10-
phenanthroline (2,9-Br2phen), 3,8-dibromo-1,10-phenanthroline (3,8-Br2phen) or 4,7-dibromo-1,10-
phenanthroline (4,7-Br2phen) and PˆP is bis(2-(diphenylphosphano)phenyl)ether (POP) or 4,5-bis
(diphenylphosphano)-9,9-dimethylxanthene (xantphos). The compounds were characterized by
solution multinuclear NMR spectroscopy, mass spectrometry and a single-crystal X-ray analysis.
Each compound underwent a partially reversible or irreversible copper-centred oxidation, the highest
potential being for 2,9-Br2phen-containing compounds. In solution, the compounds are weak yellow
or orange emitters, whereas powdered samples exhibit yellow emissions with photoluminescence
quantum yields of up to 45% for [Cu(xantphos)(2,9-Br2phen)][PF6] with an excited state lifetime τ1/2
= 9.9 µs. Values of λemmax for [Cu(POP)(2,9-Br2phen)][PF6] and [Cu(xantphos)(2,9-Br2phen)][PF6]
are blue-shifted with respect to compounds with the 3,8-and 4,7-isomers, both in solution and in the
solid state.
Keywords: copper(I); 1,10-phenanthroline; bromo-substitution; photophysical properties
1. Introduction
The ground-breaking work of McMillin and coworkers [1,2] paved the way to the understanding
and subsequent exploitation of the photoluminescent behaviour of the metal-to-ligand charge transfer
(MLCT) state of heteroleptic copper(I) coordination compounds containing 1,10-phenanthroline (phen)
or 2,2′-bipyridine (bpy) combined with phosphane or bis(phosphane) ligands. More recently, it has
emerged that these [Cu(PˆP)(NˆN)]+ complexes exhibit thermally activated delayed fluorescence
(TADF) [3–5], a phenomenon in which the first excited singlet state is populated by a thermally
activated transition from the first excited triplet state resulting in a corresponding improvement in
the emission properties of the compounds. As a consequence, [Cu(PˆP)(NˆN)]+ compounds are of
significant interest for application in light-emitting electrochemical cells (LECs) which represent a
potential new approach to the development of solid-state lighting technologies [6–8]. LECs based
on ionic transition-metal complexes (iTMCs) have conventionally been based on ruthenium(II) or
iridium(III) compounds [6,9]. These heavier d-block metals were initially selected because the large
spin-orbit coupling leads to singlet-triplet mixing, consequently allowing harvesting of both singlet
and triplet excitons [6]. However, interest in copper-based iTMCs has grown [10–12], motivated,
in part, by the lower cost and higher natural abundance of copper with respect to the heavier d-block
metal, and the opportunity to harvest all spin-states through a TADF mechanism.
Of the mononuclear [Cu(PˆP)(NˆN)]+ complexes reported to date, the most common PˆP ligands are
xantphos (4,5-bis(diphenylphosphano)-9,9-dimethylxanthene, IUPAC PIN (9,9-dimethyl-9H-xanthene-
Inorganics 2020, 8, 4; doi:10.3390/inorganics8010004 www.mdpi.com/journal/inorganics
Inorganics 2020, 8, 4 2 of 17
4,5-diyl)bis(diphenylphosphane)) and POP (bis(2-(diphenylphosphano)phenyl)ether, IUPAC PIN
oxydi(2,1-phenylene)bis(diphenylphosphane)) (Scheme 1). The majority of the NˆN ligands possess a
bpy or phen metal-binding domain. We have focused on bpy-derived ligands and have shown
that 6-alkyl, 6,6′-dialkyl or 6-alkyloxy substituted bpy ligands with sterically non-demanding
groups lead to some of the best-performing LECs [10,13,14]. These conclusions are further
supported by the results of Costa, Barolo and coworkers, who have demonstrated the beneficial
effects of using the 6,6′-dimethoxy-2,2′-bipyridine ligand in [Cu(POP)(NˆN)]+ emitters [15].
Our investigations of [Cu(POP)(NˆN)]+ and [Cu(xantphos)(NˆN)]+ complexes containing 6-halo-
and 6,6′-dihalo-2,2′-bipyridine ligands have shown that Cl and Br atoms are less effective than
methyl groups in the enhancement of the emission of [Cu(PˆP)(bpy)][PF6] compounds. Nonetheless,
several of these halo-containing compounds exhibit moderately good photophysical properties
with [Cu(xantphos)(6-Brbpy)][PF6], [Cu(POP)(6,6′-Cl2bpy)][PF6], [Cu(xantphos)(6,6′-Cl2bpy)][PF6]
showing photoluminescence quantum yields (PLQYs) of 16.3%, 14.8% and 17.1%, respectively, in the
solid state [16]. LECs with [Cu(POP)(6,6′-Cl2bpy)][PF6] and [Cu(xantphos)(6,6′-Cl2bpy)][PF6] in the
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Scheme  1.  Structures  of  POP  and  xantphos.  Atom  labels  are  used  for  the  NMR  spectroscopic 
assignments; phenyl rings  in the PPh2 units are  labelled D, and ring  labels are consistent with our 
previous publications in this area. 
In solution, dynamic ligand redistribution is often a problem with heteroleptic [Cu(P^P)(N^N)]+ 
compounds,  resulting  in mixtures  containing  both  the  heteroleptic  complex  and  the  homoleptic 
[Cu(N^N)2]+ and [Cu(P^P)2]+ species (Equation (1)). When P^P is bulky, as in the case of POP, three 
coordinate  [Cu(P^P)(solv)]+  (solv  =  solvent  such  as MeCN)  complexes may  also  be  formed  [17]. 
When N^N  is a bpy‐derivative, synthetic strategies can be adapted to favour the formation of the 




is  sterically  hindered  (e.g.,  POP)  [20].  They  have  also  provided  valuable  insight  into  structure–
property relationships for a series of [Cu(P^P)(phen)]+ and [Cu(P^P)(4,7‐Ph2phen)]+ (4,7‐Ph2phen = 
4,7‐diphenyl‐1,10‐phenanthroline)  [11].  In particular,  they observed  that  the  larger  the number of 
intramolecular π‐interactions  in  the ground‐state complex,  the higher  the PLQY. The presence of 
these π‐interactions  restricts  the  flattening of  the copper coordination sphere  in  the excited state. 
Phenomenologically, this parallels the beneficial effects of intramolecular π‐interactions observed in 
cyclometallated iridium(III) emitters [21,22]. 
2[Cu(P^P)(N^N)]+  ⇌ ሾCu(N^N)2]+ + [Cu(P^P)2]+  (1) 
While a range of [Cu(P^P)(N^N)]+ complexes with alkyl‐ or aryl‐substituted phen ligands has 
been  investigated  [12],  there  are  few  reports  of  [Cu(P^P)(N^N)]+  complexes  containing  simple 
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[ u( ˆ ) ]+ and [Cu(PˆP)2]+ species (Equation (1)). When PˆP is bulky, as in the case of POP, three
coordinate [Cu(PˆP)(solv)]+ (solv = solvent such as MeCN) complexes may also be formed [17]. When
NˆN is a bpy-derivative, synthetic strategies can be adapted to favour the formation of the heteroleptic
compounds [18,19]. For NˆN ligands based upon phen metal-binding domains, Armaroli, Nierengarten,
Delavaux- icot and coworkers have carried out detailed investigations of the ligand redistribution
reactions occurring in [Cu(PˆP)(NˆN)]+ complexes, and have demonstrated that 2,9-substituted phen
ligands favour the right-hand side of equilibrium (1) unless the PˆP ligand is sterically hindered (e.g.,
POP) [20]. They have also provided valuable insight into structure–property relationships for a series of
[Cu(PˆP)(phen)]+ and [Cu(PˆP)(4,7-Ph2phen)]+ (4,7-Ph2phen = 4,7-diphenyl-1,10-phenanthroline) [11].
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of the copper coordination sphere in the excited state. Phenomenologically, this parallels the beneficial





While a range of [Cu(PˆP)(NˆN)]+ complexes with alkyl- or aryl-substituted phen ligands
has been investigated [12], there are few reports of [Cu(PˆP)(NˆN)]+ complexes containing simple
halo-substituted phen ligands. The study of chelating bisphosphane ligands arose from the
observations of Casadonte and McMillin who demonstrated non-equilibrated emissions from
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two triplet excited states in a series of compounds, including [Cu(PPh3)2(5-Clphen)][BF4] and
[Cu(PPh3)2(4,7-Cl2phen)][BF4] in a 4:1 EtOH/MeOH frozen glass at 77 K [23]. Further examples come
from more recent investigations. Solid [Cu(bdpp)(phen)][ClO4] and [Cu(bdpp)(3,8-Br2phen)][ClO4]
(bdpp = 1,2-bis(diphenylphosphane)benzene, and 3,8-Br2phen is shown in Scheme 2) emit at
553 and 570 nm, respectively (λexc = 300–430 nm) with PLQY values of 18.33% and 3.58%,
respectively [24]. Xin et al. have reported that in the solid state, the dinuclear compounds
[(3,8-Br2phen)Cu(µ-Ph2P(CH2)nPPh2)2Cu(3,8-Br2phen)][ClO4]2 exhibit emission maxima at 543, 565,
559 and 566 nm for n = 1, 4, 5 and 6, respectively (λexc = 330 nm); for n = 5, the PLQY value
is 17.4%. These compounds emit weakly in CH2Cl2 solution, but in mixtures of CH2Cl2 and
hexane, they exhibit aggregation-induced phosphorescent emission [25]. Feng et al. [26] have
demonstrated that [Cu(xantphos)(3,8-Br2phen)][ClO4] and [Cu(BINAP)(3,8-Br2phen)][ClO4] (BINAP
= 2,2′-bis(diphenylphosphano)-1,1′-binaphthalene) are emissive in the solid state (λexc = 365 nm),
but no PLQY values were reported. A recent investigation of the impact of halo-substituents on the
photophysical behaviour of the homoleptic complexes [Cu(2,9-X2phen)2][PF6] where X = Cl, Br or I is
also relevant. This reveals that for X = Br and I, PLQY values for [Cu(2,9-X2phen)2][PF6] are higher
than for [Cu(phen)2][PF6]. Significantly, whereas [Cu(2,9-Cl2phen)2][PF6] and [Cu(2,9-Br2phen)2][PF6]
exhibit TADF, for [Cu(2,9-I2phen)2][PF6] the PLQY increases as temperature decreases as a consequence
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We  now  report  an  extension  of  our  earlier  investigation  of  [Cu(POP)(N^N)]+  and 
[Cu(xantphos)(N^N)]+ complexes containing 6‐halo‐ and 6,6′‐dihalo‐2,2′‐bipyridine ligands [16] to a 




We  have  previously  discussed  the  need  for  different  strategies  for  the  preparations  of 
[Cu(POP)(N^N][PF6]  and  [Cu(xantphos)(N^N][PF6]  compounds  in  which  the  N^N  ligand  is  a 
derivative of bpy  [10,14]. Similarly, different approaches were used  to optimize  the yields of  the 
heteroleptic copper(I) complexes containing the dibromophen ligands and either POP or xantphos. 
[Cu(POP)(2,9‐Br2phen)][PF6],  [Cu(POP)(3,8‐Br2phen)][PF6]  and  [Cu(POP)(4,7‐Br2phen)][PF6]  were 
prepared by first combining POP and  [Cu(MeCN)4][PF6]  in CH2Cl2 and  then, after  stirring  for an 
hour,  adding  the  appropriate  Br2phen.  In  contrast,  the  series  of  [Cu(xantphos)(Br2phen)][PF6] 
compounds were  synthesized by  adding  a  CH2Cl2  solution  of  xantphos  and  either  2,9‐Br2phen, 
3,8‐Br2phen  or  4,7‐Br2phen  to  a  CH2Cl2  solution  of  [Cu(MeCN)4][PF6]  and  stirring  at  room 
temperature for 90 min. Each product was purified by crystallization by vapour diffusion of Et2O 
into a CH2Cl2 solution of the crude material. 
Satisfactory  elemental  analyses  were  obtained  for  all  the  heteroleptic  copper(I)  complexes 
expect  for  [Cu(POP)(2,9‐Br2phen)][PF6], and  for  the  latter, a high‐resolution electrospray  (HR ESI) 
mass  spectrum  was  recorded  (Figure  S1,  see  Supporting  Information).  The  electrospray  mass 
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no report an extension of our earlier investigation of [Cu(POP)( ˆN)]+
ˆ + complexes containing 6-halo- and 6,6′-dihalo-2,2′-bipyridine ligands [16]
to a series of [Cu(POP)(Br2phen)][PF6] and [Cu(xantphos)(Br2phen][PF6] compounds in i r2
t t t ree is ers s o n in Sche e 2.
2. Results and Discussion
2.1. Synthesis and Characterization of Copper(I) Complexes
We have previously discussed the need for different strategies for the preparations of
[Cu(POP)(NˆN][PF6] and [Cu(xantphos)(NˆN][PF6] compounds in which the NˆN ligand is a
derivative of bpy [10,14]. Similarly, different approaches were used to optimize the yields of the
heteroleptic copper(I) complexes containing the dibromophen ligands and either POP or xantphos.
[Cu(POP)(2,9-Br2phen)][PF6], [Cu(POP)(3,8-Br2phen)][PF6] and [Cu(POP)(4,7-Br2phen)][PF6] were
prepared by first combining POP and [Cu(MeCN)4][PF6] in CH2Cl2 and then, after stirring for an hour,
adding the appropriate Br2phen. In contrast, the series of [Cu(xantphos)(Br2phen)][PF6] compounds
were synthesized by adding a CH2Cl2 solution of xantphos and either 2,9-Br2phen, 3,8-Br2phen or
4,7-Br2phen to a CH2Cl2 solution of [Cu(MeCN)4][PF6] and stirring at room temperature for 90 min.
Each product was purified by crystallization by vapour diffusion of Et2O into a CH2Cl2 solution of the
crude material.
Satisfactory elemental analyses were obtained for all the heteroleptic copper(I) complexes expect
for [Cu(POP)(2,9-Br2phen)][PF6], and for the latter, a high-resolution electrospray (HR ESI) mass
spectrum was recorded (Figure S1, see Supporting Information). The electrospray mass spectrum of
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each of [Cu(POP)(2,9-Br2phen)][PF6], [Cu(POP)(3,8-Br2phen)][PF6] and [Cu(POP)(4,7-Br2phen)][PF6]
exhibited a peak corresponding to the [M − PF6]+ ion at m/z 939.02, 938.96 and 938.98, respectively
(Figures S2–S4). For [Cu(POP)(2,9-Br2phen)][PF6], the base peak was observed at m/z 601.09 and was
assigned to the [Cu(POP)]+ ion (Figure S2), whereas in the mass spectra of the compounds containing
3,8-Br2phen and 4,7-Br2phen, the peak for the [Cu(POP)]+ ion (m/z 601.06 and 601.011, respectively) was
of low intensity. Similarly, the base peak in the ESI mass spectrum of [Cu(xantphos)(2,9-Br2phen)][PF6]
arose from the [Cu(xantphos)]+ ion (m/z 641.13), with the [M − PF6]+ ion giving a lower intensity
peak at m/z 979.03 (Figure S5). In the mass spectra of [Cu(xantphos)(3,8-Br2phen)][PF6] and
[Cu(xantphos)(4,7-Br2phen)][PF6], the peak arising from the [M − PF6]+ ion (m/z 979.03 and 979.00,
respectively, Figures S6 and S7) was of significantly greater intensity than that assigned to the
[Cu(xantphos)]+ ion (m/z 641.12 and 641.15, respectively). These differences may be attributed to the
steric effects of the 2,9-dibromo substituents compared to the 3,8- and 4,7-substitution pattern, and are
manifested in the crystallographic data discussed later.
The solution 1H, 13C{1H} and 31P{1H} NMR spectra of the copper(I) complexes were recorded
in acetone-d6. Each 31P{1H} NMR spectrum exhibited a broadened singlet in the range δ −10.1
to −12.4 ppm (see Methods and Materials Section) arising from the POP or xantphos ligand, in
addition to a septet at δ −144.2 ppm assigned to the [PF6]− ion. The 1H and 13C{1H} NMR spectra
were assigned using COSY, NOESY, HMQC and HMBC methods and Figures S8–S25 show the 1H
NMR, HMQC and HMBC spectra. As a representative example, the aromatic regions of the 1H
NMR spectra of [Cu(POP)(3,8-Br2phen)][PF6] and [Cu(xantphos)(3,8-Br2phen)][PF6] are compared
in Figure 1. The change in the multiplicity of the signal for HC5 and the disappearance of the
signal for HC6 on going from [Cu(POP)(3,8-Br2phen)][PF6] to [Cu(xantphos)(3,8-Br2phen)][PF6] is
consistent with the introduction of the CMe2 unit in xantphos (see Scheme 1). The methyl groups
of the CMe2 group give rise to a singlet at δ 1.74 ppm in [Cu(xantphos)(2,9-Br2phen)][PF6], at δ
1.87 ppm in [Cu(xantphos)(3,8-Br2phen)][PF6] and at δ 1.81 ppm in [Cu(xantphos)(4,7-Br2phen)][PF6].
In contrast to the solid-state structures described below, the molecular symmetry inferred from the room
temperature 1H, 13C{1H} and 31P{1H} NMR spectra is consistent with dynamic behaviour analogous
to that described for related bpy-containing compounds [14,19]. A comparison of Figure 1a with
Figure 1b reveals that the signal for proton HA2 undergoes a significant shift to lower frequency on
going from [Cu(POP)(3,8-Br2phen)][PF6] to [Cu(xantphos)(3,8-Br2phen)][PF6]. This is a consequence
of the proximity of HA2 to the xanthene unit which has a “bowl” conformation (see the structural
discussion of [Cu(xantphos)(3,8-Br2phen)][PF6] below). Inversion of the “bowl” [14,19] renders the
phenanthroline unit C2 symmetric on the NMR timescale at room temperature with both HA2 protons
experiencing the effects of being positioned over the xanthene unit. We have seen similar effects in
[Cu(xantphos)(6-Rbpy)]+ compounds in which proton HA6 (which is in the unsubstituted pyridine
ring and is adjacent to the N atom) appears at very different chemical shifts, depending on whether it
is located over or remote from the xanthene “bowl” [14,19].
Since the solution photophysical and electrochemical properties of the compounds were
investigated in CH2Cl2, we confirmed the stability of the heteroleptic complexes in this solvent.
The 1H NMR spectrum of a CD2Cl2 solution of [Cu(POP)(4,7-Br2phen)][PF6] did not change over
a period of 6 h at room temperature (Figure S26a). In the NOESY spectrum (Figure S26b), a cross
peak between signals for protons HA2 (on the 4,7-Br2phen ligand) and HD2 (on POP) confirms the
heteroleptic nature of the complex.
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from  [Cu(POP)(3,8‐Br2phen)][PF6]  to  [Cu(xantphos)(3,8‐Br2phen)][PF6]  is  consistent  with  the 
introduction of the CMe2 unit in xantphos (see Scheme 1). The methyl groups of the CMe2 group give 
rise  to  a  singlet  at  δ  1.74  ppm  in  [Cu(xantphos)(2,9‐Br2phen)][PF6],  at  δ  1.87  ppm  in 
[Cu(xantphos)(3,8‐Br2phen)][PF6] and at δ 1.81 ppm in [Cu(xantphos)(4,7‐Br2phen)][PF6]. In contrast 













Figure 1. The aromatic region of the 1H NMR spectra (500 MHz, acetone-d6, 298 K) of (a)
[Cu(POP)(3,8-Br2phen)][PF6] and (b) [Cu(xantphos)(3,8-Br2phen)][PF6]. See Schemes 1 and 2 for
atom labels. Chemical shifts in δ/ppm.
2.2. Crystal Structures
Yellow single crystals of [Cu(POP)(2,9-Br2phen)][PF6]·0.5Et2O, [Cu(POP)(3,8-Br2phen)][PF6]·
0.8CH2Cl2·0.9H2O, [Cu(POP)(4,7-Br2phen)][PF6]·CH2Cl2, [Cu(xantphos)(2,9-Br2phen)][PF6]·1.1CH2Cl2,
[Cu(xantphos)(3,8-Br2phen)][PF6]·1.1CH2Cl2·0.7Et2Oand[Cu(xantphos)(4,7-Br2phen)][PF6]·CH2Cl2·0.9Et2O
were grown from CH2Cl2 solutions of the compounds layered with Et2O. In [Cu(xantphos)(2,9-Br2phen)]
[PF6]·1.1CH2Cl2, the xantphos ligand is disordered and has been modelled over two sites of equal
occupancies, the sites of the xanthene unit being related by a mirror plane. The asymmetric unit
contains half of the 2,9-Br2phen ligand and the second half is generated by a mirror plane. Associated
with this is the disorder of three of the four phenyl rings of the PPh2 units. Because of the extent of
disorder, we will not discuss this structure in detail but merely comment that it provides confirmation
that the 2,9-Br2phen ligand is present in a chelating mode despite the steric hindrance of the two
bromo-substituents adjacent to the N-donors. The structures of the [Cu(PˆP)(NˆN)]+ cations in the
remaining structures are displayed in Figures 2 and 3. A comparison of the Cu–N and Cu–P bond
lengths and of the N–Cu–N and P–Cu–P bond angles is provided in Table 1. Because of the rigidity
of the chelating phen unit, the N–Cu–N angle is close to 80◦ in all structures. The POP ligand is
conformationally flexible and the P–Cu–P bond angle ranges from 118.00(3)◦ to 112.37(2)◦, the angle
becoming smaller along the series 2,9-Br2phen > 3,8-Br2phen > 4,7-Br2phen (Table 1). The same trend
is observed for the xantphos-containing cations, although the range of angles is smaller (Table 1). The
distorted 4-coordinate geometry of the copper(I) atom in each complex cation is typical of heteroleptic
[Cu(PˆP)(NˆN)]+ complexes. Using Houser’s τ4 parameter [28], the values of 0.83 to 0.88 (Table 1)
illustrate distortion towards C3v symmetry for which τ4 = 0.85; for Td symmetry, τ4 = 1.00. We note
that the unit cell dimensions for [Cu(POP)(2,9-Br2phen)][PF6]·Et2O (see the Materials and Methods
section) are very similar to those reported for [Cu(POP)(2,9-Me2phen)][PF6]·Et2O [29] (Cambridge
Strucural Database, CSD, refcode CAPZID [30]).
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Figure  2.  The  structures  of  the  POP‐containing  cations  with  H  atoms  omitted.  (a) 
[Cu(POP)(2,9‐Br2phen)]+  (ellipsoids  plotted  at  50%  probability),  (b)  [Cu(POP)(3,8‐Br2phen)]+ 
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Figure 2. The structures of the POP-containi g cations with H atoms omitted. (a) [Cu(POP)
(2,9-Br2phen)]+ (ellipsoids plotted at 50% probability), (b) [Cu(POP (3,8-Br2phen)]+ (ellipsoids
plott d at 40% probability) and (c) [Cu(POP)(4,7-Br2phen)]+ (elli soids plotted at 50% probability).
In [Cu(POP)(2,9-Br2phen)][PF6]·0.5Et2O and [Cu(POP)(4,7-Br2phen)][PF6]·CH2Cl2, there are two








Figure  3. The  structures  of  the  cations  in  [Cu(xantphos)(3,8‐Br2phen)][PF6]∙1.1CH2Cl2∙0.7Et2O  and 
[Cu(xantphos)(4,7‐Br2phen)][PF6]∙CH2Cl2∙0.9Et2O with ellipsoids plotted at 40% probability level and 
H atoms omitted for clarity. (a) [Cu(xantphos)(3,8‐Br2phen)]+ and (b) [Cu(xantphos)(4,7‐Br2phen)]+. 
Table  1.  Comparison  of  the  bond  lengths  and  angles  in  the  coordination  spheres  of  the 
[Cu(P^P)(N^N)][PF6] complexes. 
[Cu(P^P)(N^N)]+ Cation 1  Cu–N/Å  Cu–P/Å  P–Cu–P/Deg  N–Cu–N/Deg  τ4 2 
[Cu(POP)(2,9‐Br2phen)]+ 
Cation 1  2.100(2), 2.135(2)  2.2742(7), 2.2416(7)  118.00(3)  79.61(8)  0.87 
[Cu(POP)(2,9‐Br2phen)]+ 
Cation 2  2.149(2), 2.129(2)  2.2849(7), 2.2704(7)  116.47(3)  78.46(9)  0.87 
[Cu(POP)(3,8‐Br2phen)]+    2.055(6), 2.083(5)    2.2468(17), 2.2332(18)  115.65(7)  80.9(2)  0.88 
[Cu(POP)(4,7‐Br2phen)]+ 
Cation 1  2.0797(19), 2.0607(19)  2.2622(7), 2.2377(7)  112.37(2)  80.22(7)  0.84 
[Cu(POP)(4,7‐Br2phen)]+ 
Cation 2  2.088(2), 2.0683(19)  2.2694(7), 2.2370(7)  112.52(3)  80.34(8)  0.85 
[Cu(xantphos)(2,9‐Br2phen)]+  2.115(4), 2.115(4) 3  2.295(2), 2.2523(18)  117.97(8)  79.2(2)  0.83 
[Cu(xantphos)(3,8‐Br2phen)]+  2.079(2), 2.122(2)  2.2495(7), 2.2752(7)  116.57(3)  80.45(8)  0.87 
[Cu(xantphos)(4,7‐Br2phen)]+  2.075(4), 2.069(5)  2.2619(15), 2.2591(15)  115.36(6)  80.29(16)  0.87 
1  In[Cu(POP)(2,9‐Br2phen)][PF6]∙0.5Et2O  and  [Cu(POP)(4,7‐Br2phen)][PF6]∙CH2Cl2,  there  are  two 
independent ions pairs in the asymmetric unit. 2 τ4 parameter, see reference [28]. 3 The N atoms are 
symmetry‐related (symmetry code x, 1−y, z). 




Figure 3. The structures of the cations in [Cu(xantphos)(3,8-Br2phen)][PF ]·1.1CH2Cl2·0.7Et2O and
[Cu(xantphos)(4,7-Br2phen)][PF6]·CH2Cl2·0.9Et2 it ellipsoids plotted at 40% pro ability l vel and
H atoms omitted for clarity. (a) [Cu(xantphos)(3,8-Br2 and (b) [Cu(xantphos)(4,7-Br2phen)]+.
Table 1. Comparison of the bond lengths and angles in the coordination spheres of the
[Cu(PˆP)(NˆN)][PF6] complexes.
[Cu(PˆP)(NˆN)]+ Cation 1 Cu–N/Å Cu–P/Å P–Cu–P/Deg N–Cu–N/Deg τ4 2
[Cu(POP)(2,9-Br2phen)]+
Cation 1 2.100(2), 2.135(2) 2.2742(7), 2.2416(7) 118.00(3) 79.61(8) 0.87
[Cu(POP)(2,9-Br2phen)]+
Cation 2 2.149(2), 2.129(2) 2.2849(7), 2.2704(7) 116.47(3) 78.46(9) 0.87
[Cu(PO )(3,8-Br2phen)]+ 2.055(6), 2.083(5) 2.2468(17), 2.2332(18) 115.65(7) 80.9(2) 0.88
[Cu(POP)(4,7-Br2phen)]+
Cation 1 2.0797(19), 2.0607(19) 2.2622(7), 2.2377(7) 112.37(2) 80.22(7) 0.84
[Cu(POP)(4,7-Br2phen)]+
Cation 2 2.088(2), 2.0683(19) 2.2694(7), 2.2370(7) 112.52(3) 80.34(8) 0.85
[Cu(xantphos)(2,9-Br2phen)]+ 2.115(4), 2.115(4) 3 2.295(2), 2.2523(18) 117.97(8) 79.2(2) 0.83
[Cu(xantphos)(3,8-Br2phen)]+ 2.079(2), 2.122(2) 2.2495(7), 2.2752(7) 116.57(3) 80.45(8) 0.87
[Cu(xantphos)(4,7-Br2phen)]+ 2.075(4), 2.069(5) 2.2619(15), 2.2591(15) 115.36(6) 80.29(16) 0.87
1 In[Cu(POP)(2,9-Br2phe )][PF6]·0.5Et2O and [Cu(POP)(4,7-Br2phen)][PF6]·CH2Cl2, there are two independent ions
pairs in the asymmetric unit. 2 τ4 parameter, see reference [28]. 3 The N atoms are symmetry-related (symmetry
code , 1−y, z .
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The asymmetric units in [Cu(POP)(2,9-Br2phen)][PF6]·0.5Et2O and [Cu(POP)(4,7-Br2phen)]
[PF6]·CH2Cl2 contain two independent ion-pairs. The bond parameters in the coordination spheres
of the copper centres are similar (Table 1). Figure 4 illustrates an overlay of the independent
[Cu(POP)(4,7-Br2phen)]+ cations with the POP ligands approximately superimposed.Inorganics 2020, 8, x FOR PEER REVIEW  7 of 17 
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coloured by element colour, and (b) coloured to show the individual cations. 
In the solid state, [Cu(POP)(N^N]+ and [Cu(xantphos)(N^N]+ cations often exhibit intra‐cation 






respectively.  No  analogous  interaction  is  observed  in  [Cu(POP)(2,9‐Br2phen)][PF6],  and  a 
contributing factor may be the effects that the bromo‐substituents  in the 2,9‐positions have on the 
orientations of the phenyl rings. We note, however, that the cations are closely associated in the solid 
state  structure,  as  exemplfied  for  [Cu(POP)(2,9‐Br2phen)][PF6]∙0.5Et2O  in  Figure  6,  and  there  is 
clearly an interplay of intra‐ and inter‐cation interactions in all the structures. Intra‐cation π‐stacking 





one  arene  ring  of  the  POP  backbone  in  (a)  [Cu(POP)(3,8‐Br2phen)]+  and  (b)  the  independent 
[Cu(POP)(4,7‐Br2phen)]+  cations.  (c)  Space‐filling  representation  of  the  π‐stacking  between  two 
phenyl rings of different PPh2 units in [Cu(xantphos)(4,7‐Br2phen)]+. 
Fig re 4. Overlay of the two indepen ent cations in [Cu(POP)(4,7-Br2phen)][PF6]·CH2Cl2: (a) coloured
by element colour, and (b) coloured to show the individual cations.
In the solid state, [Cu(POP)(NˆN]+ and [Cu(xantphos)(NˆN]+ cations often exhibit intra-cation
pi-stacking contacts. [Cu(POP)(NˆN]+ cations tend to show face-to-face pi-stacking between one
phenyl ring of a PPh2 unit and one arene ring of the POP backbone, while face-to-face pi-stacking
between two phenyl rings of different PPh2 units is often a feature of [Cu(xantphos)(NˆN]+ cations,
see for example [10]. The cations in [Cu(POP)(3,8-Br2phen)][PF6] and [Cu(POP)(4,7-Br2phen)][PF6]
all show pi-stacking between one phenyl ring and the POP backbone (Figure 5) with angles between
the ring planes of 27.7 (Figure 5a), 27.9 and 17.1◦ (Figure 5b) and centroid distances 4.1, 4.0 and 3.8 Å,
respectively. No analogous interaction is observed in [Cu(POP)(2,9-Br2phen)][PF6], and a contributing
factor may be the effects that the bromo-substituents in the 2,9-positions have on the orientations of
the phenyl rings. We note, however, that the cations are closely associated in the solid state structure,
as exemplfied for [Cu(POP)(2,9-Br2phen)][PF6]·0.5Et2O in Figure 6, and there is clearly an interplay
of intra- and inter-cation interactions in all the structures. Intra-cation pi-stacking is observed in the
[Cu(xantphos)(4,7-Br2phen)]+ cation as shown in Figure 5c; the interaction is characterized by an angle
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respectively.  No  analogous  interaction  is  observed  in  [Cu(POP)(2,9‐Br2phen)][PF6],  and  a 
contributing factor may be the effects that the bromo‐substituents  in the 2,9‐positions have on the 
orientations of the phenyl rings. We note, however, that the cations are closely associated in the solid 
state  structure,  as  exemplfied  for  [Cu(POP)(2,9‐Br2phen)][PF6]∙0.5Et2O  in  Figure  6,  and  there  is 
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one  arene  ring  of  the  POP  backbone  in  (a)  [Cu(POP)(3,8‐Br2phen)]+  and  (b)  the  independent 
[Cu(POP)(4,7‐Br2phen)]+  cations.  (c)  Space‐filling  representation  of  the  π‐stacking  between  two 
phenyl rings of different PPh2 units in [Cu(xantphos)(4,7‐Br2phen)]+. 
Figure 5. Space-filling representations of the pi-stacking between one phenyl ring of a PPh2 unit
and one arene ring of the POP backbone in (a) [ u(P P)(3,8-Br2phen)]+ and (b) the independent
[Cu(P P)(4,7-Br2phen)]+ cations. (c) Space-filling representation of the pi-stacking between t o phenyl
rings of different PPh2 units in [Cu(xantphos)(4,7-Br2phen)]+.




Figure  6.  Packing  of  independent  cations  (red  and  pale  blue)  into  chains  in 




recorded  and  Table  2  gives  the  potentials  of  the  electrochemical  processes.  Each  compound 
undergoes a partially‐reversible or irreversible oxidation assigned to a Cu+/Cu2+ process. The degree 
of  reversiblity  for  [Cu(POP)(3,8‐Br2phen)][PF6],  [Cu(POP)(4,7‐Br2phen)][PF6]  and 
[Cu(xantphos)(2,9‐Br2phen)][PF6]  is  demonstrated  by  the  Ipc/Ipa  ratios  in  Table  2.  We  note  that 
changing  the  solvent  from CH2Cl2  to  4‐methyl‐1,3‐dioxolan‐2‐one  (propylene  carbonate)  did  not 
improve the reversiblity of the Cu+/Cu2+ processes. If the forward CV scan is taken beyond +1.2 V, a 
second  (fully  irreversible) process  is  observed  around  +1.3 V  and  this  is  assigned  to phosphane 
oxidation. A representative CV  is shown  in Figure S27, and anodic and cathodic scans  for all  the 
compounds are displayed in Figures S28–S33. The copper(I) oxidation occurs at highest potentials 
for  [Cu(POP)(2,9‐Br2phen)][PF6]  and  [Cu(xantphos)(2,9‐Br2phen)][PF6],  consistent  with  the  steric 
effects  of  the  bromo‐substituents  in  the  2,9‐positions  which  hinder  flattening  of  the  copper 
coordination  sphere  during  oxidation.  The  same  trend  is  observed  on  going  from 
[Cu(POP)(phen)][BF4] to [Cu(POP)(2,9‐Me2phen)][BF4] for the which the Cu+/Cu2+ oxidation occurs 
at  +1.23  V  and  +1.38  V,  respectively  (referenced  with  respect  to  Ag/AgCl)  [31].  Similarly,  the 
introduction  of  chloro‐  or  bromo‐substituents  into  the  6‐  and  6’‐positions  of  bpy  in 
[Cu(POP)(bpy)][PF6] or [Cu(xantphos)(bpy)][PF6] shifts the Cu+/Cu2+ oxidation from +0.72 or +0.76 V 
to +0.98 or +0.93 V, respectively for 6,6′‐Cl2bpy, and to +0.97 or +0.98 V, respectively, for 6,6′‐Br2bpy 
[16].  Multiple  ligand‐based  irreversible  reduction  processes  are  observed  for  the 
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Figure 6. Packing of independent cations (red and pale blue) into chains in [Cu(POP)(2,9-Br2phen)]
[PF6]·0.5Et O shown in space-filling representation. Anions and solvent molecules are omitted.
2.3. Electrochemistry
Cyclic voltammograms (CVs) of CH2Cl2 solutions of the [Cu(PˆP)(NˆN)][PF6] compounds were
recorded and Table 2 gives the potentials of the electrochemical processes. Each compound undergoes a
partially-reversible or irreversible oxidation assigned to a Cu+/Cu2+ process. The degree of reversiblity
for [Cu(POP)(3,8-Br2phen)][PF6], [Cu(POP)(4,7-Br2phen)][PF6] and [Cu(xantphos)(2,9-Br2phen)][PF6]
is demonstrated by the Ipc/Ipa ratios in Table 2. We note that changing the solvent from CH2Cl2 to
4-methyl-1,3-dioxolan-2-one (propylene carbonate) did not improve the reversiblity of the Cu+/Cu2+
processes. If the forward CV scan is taken beyond +1.2 V, a second (fully irreversible) process
is observed around +1.3 V and this is assigned to phosphane oxidation. A representative CV is
shown in Figure S27, and anodic and cathodic scans for all the compounds are displayed in Figures
S28–S33. The copper(I) oxidation occurs at highest potentials for [Cu(POP)(2,9-Br2phen)][PF6] and
[Cu(xantphos)(2,9-Br2phen)][PF6], consistent with the steric effects of the bromo-substituents in the
2,9-positions which hinder flattening of the copper coordination sphere during oxidation. The same
trend is observed on going from [Cu(POP)(phen)][BF4] to [Cu(POP)(2,9-Me2phen)][BF4] for the which
the Cu+/Cu2+ oxidation occurs at +1.23 V and +1.38 V, respectively (referenced with respect to
Ag/AgCl) [31]. Similarly, the introduction of chloro- or bromo-substituents into the 6- and 6’-positions
of bpy in [Cu(POP)(bpy)][PF6] or [Cu(xantphos)(bpy)][PF6] shifts the Cu+/Cu2+ oxidation from +0.72
or +0.76 V to +0.98 or +0.93 V, respectively for 6,6′-Cl2bpy, and to +0.97 or +0.98 V, respectively,
for 6,6′-Br2bpy [16]. Multiple ligand-based irreversible reduction processes are observed for the
[Cu(PˆP)(Br2phen)][PF6] compounds (Table 2). This compares to a single reduction process for
[Cu(POP)(phen)][PF6] [11].
Table 2. Cyclic voltammetric data for [Cu(PˆP)(NˆN)][PF6] complexes referenced to internal Fc/Fc+ =
0.0 V; CH2Cl2 solutions (ca. 2 × 10−3 mol dm−3) with [nBu4N][PF6] as supporting electrolyte and scan
rate of 0.1 V s−1.
Cation in
[Cu(PˆP)(NˆN)][PF6]
E1/2ox/V Epc − Epa/mV Ipc/Ipa Epc a E1/2 red/V b
[Cu(POP)(2,9-Br2phen)]+ +0.98 −2.23, −2.10, −1.92, −1.83
[Cu(POP)(3,8-Br2phen)]+ +0.86 120 0.13 −2.20, −1.94, −1.83
[Cu(POP)(4,7-Br2phen)]+ +0.79 130 0.12 −2.17, −1.93, −1.84
[Cu(xantphos)(2,9-Br2phen)]+ +0.97 105 0.19 −2.08, −1.85, −1.74
[Cu(xantphos) 3,8-Br2phen)]+ +0.87 −2. , −1.90, −1.81
[Cu(xantphos)(4,7-Br2phen)]+ +0.95 −2.17, −1.87, −1.77
a The val e is given for Epc because the process is irreversible. b The value is for Epa; the process is irreversible.
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2.4. Photophysical Properties
The absorption spectra of CH2Cl2 solutions of the copper(I) compounds are shown in Figure 7
and absorption maxima are given in Table 3. The high energy absorptions (λ < 345 nm) are assigned
to ligand-centred, spin-allowed transitions. The broad absorption bands with λmax in the range
415–420 nm (Table 3) arise from metal-to-ligand charge transfer (MLCT). The profile of the absorption
spectrum of [Cu(xantphos)(3,8-Br2phen)][PF6] is consistent with that reported for the corresponding
perchlorate salt [26]. For both the POP- and xantphos-containing complexes, Figure 7 illustrates an
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are weak yellow or orange emitters. Solution emission  spectra are displayed  in Figure 8 and  the 
emission  maxima  are  given  in  Table  4.  All  solution  PLQYs  were  <1%.  By  analogy  with  other 
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for  [Cu(POP)(2,9‐Br2phen)][PF6]  and  [Cu(xantphos)(2,9‐Br2phen)][PF6],  respectively,  are  similar  to 
λemmax = 570 nm for [Cu(POP)(2,9‐Me2phen)][BF4] in CH2Cl2 at room temperature [31]. However, the 
solution  PLQY  of  [Cu(POP)(2,9‐Me2phen)][BF4]  of  15%  is  significantly  higher  than  PLQYs  of 
Figure 7. Solution absorption spectra of the [Cu(PˆP)(NˆN)][PF6] compounds in CH2Cl2 (concentrations
in the range 1.75 × 10−5 to 3.0 × 10−5 mol dm−3).
Table 3. Solution absorption maxima for the [Cu(PˆP)(NˆN)][PF6] compounds in CH2Cl2 (concentrations
in the range 1.75 × 10−5 to 3.0 × 10−5 mol dm−3).
Cation in [Cu(PˆP)(NˆN)][PF6]
λmax/nm (εmax/dm3 mol–1 cm–1)
Ligand-Based Absorptions MLCT
[Cu(POP)(2,9-Br2phen)]+ 281 (31,100), 304 sh (19,800), 346 (2900) 415 (2400)
[Cu(POP)(3,8-Br2phen)]+
283 (39,100), 302 sh (22,500), 319 sh (16,200),
346 (2900) 418 (3700)
[ u(P P)(4,7-Br2phen)]+ 274 (52,000), 309 sh (17,000), 327 sh (5000) 418 (5100)
[Cu(xantphos)(2,9-Br2phen)]+ 280 (30,200), 304 sh (19,800), 346 (2900) 415 (2400)
[Cu(xantphos)(3,8-Br2phen)]+ 282 (41,700), 320 sh (12,500), 346 (2900) 416 (3400)
[Cu(xantphos)(4,7-Br2phen)]+ 275 (54,500), 309 sh (12,200), 327 sh (5000) 420 (4500)
When excited into the MLCT region, deaerated CH2Cl2 solutions of the copper(I) compounds
are weak yellow or orange emitters. Solution emission spectra are displayed in Figure 8 and
the emission maxima are given in Table 4. All solution PLQYs were <1%. By analogy with
other [Cu(PˆP)(NˆN)]+ complexes [14], the emissions are assigned to dpi(Cu)→pi*(diimine) (3MLCT)
transitions. For [Cu(POP)(2,9-Br2phen)][PF6] and [Cu(xantphos)(2,9-Br2phen)][PF6], there is a
significant blue-shift in the emission (λemmax = 596 and 582 nm, respectively) compared to the
compounds with 3,8-Br2phen and 4,7-Br2phen (λemmax is between 653 and 660 nm). This indicates a
higher energy MLCT excited state for the 2,9-Br2phen-containing complexes and is consistent with
the higher oxidation potentials discussed above (Table 2). The emission maxima of 596 and 582 nm
for [Cu(POP)(2,9-Br2phen)][PF6] and [Cu(xantphos)(2,9-Br2phen)][PF6], respectively, are similar to
λemmax = 570 nm for [Cu(POP)(2,9-Me2phen)][BF4] in CH2Cl2 at room temperature [31]. However,
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the solution PLQY of [Cu(POP)(2,9-Me2phen)][BF4] of 15% is significantly higher than PLQYs of
[Cu(POP)(2,9-Br2phen)][PF6] and [Cu(xantphos)(2,9-Br2phen)][PF6]. It is well established that the
presence of sterically demanding substituents in the phen ligand are critical for suppressing exciplex
quenching [31], but the similarities in the crystal structures of [Cu(POP)(2,9-Br2phen)][PF6]·Et2O and
[Cu(POP)(2,9-Me2phen)][PF6]·Et2O (see earlier discussion) indicate that steric effects are unlikely to be
the cause of the low PLQYs for the 2,9-Br2phen-containing compounds. It is also worth noting that
Pellegrin, Daniel and coworkers reported that solution PLQYs for homoleptic [Cu(2,9-X2phen)2][PF6]
(X = Cl, Br, I) are higher than that of Cu(2,9-Me2phen)2][PF6] and conclude that this is “difficult to
rationalize only on steric grounds” [27].
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lower  than  PLQYs  of  66%  and  88%  for  [Cu(POP)(2,9‐Me2phen)][BARF]  and 
[Cu(xantphos)(2,9‐Me2phen)][BARF]  ([BARF]–  =  tetrakis  [3,5‐bis(trifluoromethyl)phenylborate]) 
[32].  For  comparison,  a  PLQY  of  36.6%  (λemmax  =  566  nm)  has  been  reported  for  powdered 
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Table 4. Room temperature solution emission maxima (CH2Cl2, ca. 2.0× 10−5 mol dm−3) and solid-state




λexc/nm λemmax/nm λemmax/nm a PLQY/% τ1/2/µs
[Cu(POP)(2,9-Br2phen)]+ 415 596 574 24 6.3
[Cu(POP)(3,8-Br2phen)]+ 420 655 578 3 0.9
[Cu(POP)(4,7-Br2phen)]+ 425 660 604 7 1.7
[Cu(xantphos)(2,9-Br2phen)]+ 425 582 554 45 9.9
[Cu(xantphos)(3,8-Br2phen)]+ 410 653 598 21 8.4
[Cu(xantphos)(4,7-Br2phen)]+ 420 657 580 12 4.2
a λexc = 365 nm for POP-containing compounds; λexc = 340 nm for xantphos-containing compounds.
Powdered samples of all the [Cu(POP)(NˆN)][PF6] and [Cu(xantphos)(NˆN)][PF6] compounds
are yellow or orange emitters when excited at 365 or 340 nm, with values of λemmax in the range
554–604 nm (Table 4 and Figure 9). The value of λemmax = 598 nm for [Cu(xantphos)(3,8-Br2phen)][PF6]
appears to be red-shifted with respect to that reported for solid [Cu(xantphos)(3,8-Br2phen)][ClO4]
(λemmax = 565 nm) [26], and may reflect differences in solid-state packing interactions. Each
solid-state emission maximum is blue-shifted with respect to solution (Table 4) and this is typical
of most other heteroleptic [Cu(PˆP)(NˆN)]+ complexes [14,16]. As in solution, values of λemmax for
solid-state [Cu(POP)(2,9-Br2phen)][PF6] and [Cu(xantphos)(2,9-Br2phen)][PF6] are blue-shifted with
respect to compounds with the 3,8- and 4,7-isomers, although the effect is less pronounced for the
powders. The solid-state PLQY values are highest for the complexes containing the 2,9-Br2phen
ligands (24% for [Cu(POP)(2,9-Br2phen)][PF6] and 45% for [Cu(xantphos)(2,9-Br2phen)][PF6]) and
these values are lower than PLQYs of 66% and 88% for [Cu(POP)(2,9-Me2phen)][BARF] and
[Cu(xantphos)(2,9-Me2phen)][BARF] ([BARF]– = tetrakis [3,5-bis(trifluoromethyl)phenylborate]) [32].
Inorganics 2020, 8, 4 11 of 17
For comparison, a PLQY of 36.6% (λemmax = 566 nm) has been reported for powdered
[Cu(POP)(phen)][BF4] and the excited-state lifetime of 12.75 µs for the latter [11] is similar to τ1/2
= 9.9 µs of [Cu(xantphos)(2,9-Br2phen)][PF6]. Thus, the data indicate that the incorporation of the
bromo-substituents in the 2,9-positions is less beneficial than the presence of methyl groups.
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3. Materials and Methods
3.1. General
1H, 13C{1H} and 31P{1H} NMR spectra were recorded on a Bruker Avance 500 spectrometer (Bruker
BioSpin AG, Fällanden, Switzerland) at 298 K. 1H and 13C NMR chemical shifts were referenced to the
residual solvent peaks with respect to δ(TMS) = 0 ppm and 31P NMR chemical shifts with respect to
δ(85% aqueous H3PO4) = 0 ppm. Solution absorption and emission spectra were measured using a
Shimadzu UV2600 spectrophotometer and a Shimadzu RF-5301PC spectrofluorometer, respectively
(Shimadzu Schweiz GmbH, Reinach, Switzerland). A Shimadzu LCMS-2020 instrument (Shimadzu
Schweiz GmbH) was used to record electrospray (ESI) mass spectra; high resolution ESI (HR-ESI)
mass spectra were measured on a Bruker maXis 4G QTOF instrument (Bruker BioSpin AG, Fällanden,
Switzerland). Quantum yields (CH2Cl2 solution and powder) were measured using a Hamamatsu
absolute photoluminescence quantum yield spectrometer C11347 Quantaurus-QY (Hamamatsu
Photonics, Solothurn, Switzerland). Powder emission spectra and excited state lifetimes were
measured with a Hamamatsu Compact Fluorescence lifetime Spectrometer C11367 Quantaurus-Tau
(Hamamatsu Photonics, Solothurn, Switzerland) with an LED light source (λexc = 340 or 365 nm).
Electrochemical measurements used a CH Instruments 900B potentiostat (CH Instruments, Austin, TX,
USA) with [nBu4N][PF6] (0.1 M) as supporting electrolyte and a scan rate of 0.1 V s−1; the solvent was
CH2Cl2 and solution concentrations were ca. 2 × 10−3 mol dm−3. The working electrode was glassy
carbon, the reference electrode was a leakless Ag+/AgCl (eDAQ ET069-1) and the counter-electrode
was a platinum wire. Final potentials were internally referenced with respect to the Fc/Fc+ couple.
[Cu(MeCN)4][PF6] was prepared according to the literature [33]. 3,8-Br2phen and 4,7-Br2phen
were purchased from Fluorochem (Chemie Brunschwig AG, Basel, Switzerland). 2,9-Br2phen was
prepared following a previously described route [34] and the NMR spectroscopic data matched those
reported [34,35]. Other chemicals were purchased from Sigma Aldrich (Sigma Aldrich Chemie GmbH,
Steinheim, Germany).
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3.2. General Procedures for Copper(I) Compound Synthesis
POP-containing compounds were synthesized according to the following procedure. POP (1.1 eq.)
and [Cu(MeCN)4][PF6] (1.0 eq.) were dissolved in CH2Cl2 (20 mL) and the reaction mixture was
stirred for 1 h. Then, the NˆN ligand (1.0 eq.) was added and the reaction mixture was stirred for 1
h. The solvent was then removed under reduced pressure. The residue was washed with Et2O. The
crude product was purified by crystallization from CH2Cl2/Et2O by vapour diffusion.
Compounds containing xantphos were prepared by the following procedure. A solution of the
respective phen (1.0 eq.) and xantphos (1.1 eq.) in CH2Cl2 (10 mL) was added dropwise to a CH2Cl2
solution (10 mL) of [Cu(MeCN)4][PF6] (1.0 eq.). The reaction mixture was then stirred for 90 min
before the solvent was removed under reduced pressure. The residue was washed with Et2O. The
crude product was purified by crystallization from CH2Cl2/Et2O by vapour diffusion.
3.3. [Cu(POP)(2,9-Br2phen)][PF6]
The reagents were POP (106 mg, 0.20 mmol), [Cu(MeCN)4][PF6] (66.5 mg, 0.18 mmol) and
2,9-Br2phen (60.6 mg, 0.18 mmol). [Cu(POP)(2,9-Br2phen)][PF6] was isolated as an orange solid (170
mg, 0.16 mmol, 88%). 1H NMR (500 MHz, acetone-d6) δ/ ppm 8.67 (d, J = 8.5 Hz, 2H, HA4), 8.20 (s, 2H,
HA5), 8.11 (d, J = 8.5 Hz, 2H, HA3), 7.46 (ddd, J = 8.3, 6.9, 2.1 Hz, 2H, HC4), 7.37–7.29 (m, 4H, HC5+C6),
7.29–7.24 (m, 4H, HD4), 7.24–7.18 (m, 8H, HD2), 7.16–7.10 (m, 8H, HD3), 7.09–7.06 (m, 2H, HC3). 13C{1H}
NMR (126 MHz, acetone-d6) δ/ ppm 159.4 (CC1), 144.2 (CA10a), 144.0 (CA2), 141.3 (CA4), 134.6 (CC3),
134.1 (t, JPC = 7.8 Hz, CD2), 133.2 (CC5), 132.8 (t, JPC = 17.1 Hz, CD1), 131.3 (CA3), 130.6 (CD4), 129.8
(CA4a), 129.3 (t, JPC = 4.7 Hz, CD3), 128.2 (CA5), 126.5 (CC2), 125.9 (t, JPC = 2 Hz, CC4), 120.8 (t, JPC =
2.0 Hz, CC6). 31P{1H} NMR (202 MHz, acetone-d6, 298 K) δ/ ppm −12.8 (POP), −144.2 (septet, JPF = 707
Hz, PF6−). ESI-MS positive mode m/z 939.02 [M − PF6]+ (calc. 938.98), 601.09 [Cu(POP)]+ (calc. 601.09).
HR ESI-MS positive mode m/z 938.9775 [M − PF6]+ (calc. 938.9784). Satisfactory elemental analytical
data could not be obtained.
3.4. [Cu(POP)(3,8-Br2phen)][PF6]
The reagents were POP (297 mg, 0.55 mmol), [Cu(MeCN)4][PF6] (186 mg, 0.50 mmol) and
3,8-Br2phen (168 mg, 0.50 mmol). [Cu(POP)(3,8-Br2phen)][PF6] was isolated as an orange solid (480 mg,
0.44 mmol, 89%). 1H NMR (500 MHz, acetone-d6) δ/ ppm 8.97 (m, 4H, HA2+A4), 8.24 (s, 2H, HA5), 7.46
(ddd, J = 8.9, 7.6, 1.7 Hz, 2H, HC5), 7.35 (m, 4H, HD4), 7.27–7.19 (m, 10H, HC6+D3), 7.17 (m, 8H, HD2),
7.12 (t, J = 7.6 Hz, 2H, HC4), 6.82 (m, 2H, HC3). 13C{1H} NMR (126 MHz, acetone-d6) δ/ ppm 159.1 (t, JPC
= 6.0 Hz, CC1), 151.7 (CA2), 142.3 (t, JPC = 1.9 Hz, CA10a), 140.3 (CA4), 135.0 (CC3), 134.1 (t, JPC = 8.2 Hz,
CD2), 133.4 (CC5), 131.5 (CA4a), 131.3 (CD1), 131.1 (CD4), 129.6 (t, JPC = 4.9 Hz, CD3), 128.7 (CA5), 126.3 (t,
JPC = 2.3 Hz, CC4), 124.4 (t, JPC = 15.4 Hz, CC2), 121.6 (CA3), 121.4 (t, JPC = 2.0 Hz, CC6). 31P{1H} NMR
(202 MHz, acetone-d6, 298 K) δ/ ppm −10.1 (POP), −144.2 (septet, JPF = 707 Hz, PF6−). ESI-MS positive
mode m/z 938.96 [M − PF6]+ (calc. 938.98), 601.06 [Cu(POP)]+ (calc. 601.09). Found: C 50.79, H 3.40,
N 2.56; C48H34Br2CuF6N2OP3·CH2Cl2 requires C 50.26, H 3.18, N 2.39.
3.5. [Cu(POP)(4,7-Br2phen)][PF6]
The reagents were POP (159 mg, 0.30 mmol), [Cu(MeCN)4][PF6] (99.7 mg, 0.27 mmol) and
4,7-Br2phen (90.6 mg, 0.27 mmol). [Cu(POP)(4,7-Br2phen)][PF6] was isolated as an orange solid
(270 mg, 0.25 mmol, 93%). 1H NMR (500 MHz, acetone-d6) δ/ ppm 8.88 (d, J = 5.2 Hz, 2H, HA2), 8.52
(s, 2H, HA5), 8.21 (d, J = 5.2 Hz, 2H, HA3), 7.45 (ddd, J = 8.2, 7.5, 1.7 Hz, 2H, HC5), 7.36–7.30 (m, 4H,
HD4), 7.24–7.17 (m, 10H, HC6+D3), 7.15–7.09 (m, 10H, HC4+D2), 6.87–6.81 (m, 2H, HC3). 13C{1H} NMR
(126 MHz, acetone-d6) δ/ ppm 159.3 (t, JPC = 6.1 Hz, CC1), 151.1 (CA2), 144.8 (t, JPC = 2.1 Hz, CA10a),
135.9 (t, JPC = 1.1 Hz, CA4), 135.1 (CC3), 134.0 (t, JPC = 8.2 Hz, CD2), 133.3 (CC5), 131.6 (t, JPC = 17.2
Hz, CD1), 131.0 (CD4), 130.4 (CA3/A4a), 130.3 (CA3/A4a), 129.7 (t, JPC = 4.8 Hz, CD3), 127.8 (CA5), 126.1 (t,
JPC = 2.3 Hz, CC4), 124.4 (t, JPC = 15.5 Hz, CC2), 121.6 (t, JPC = 2.1 Hz, CC6). 31P{1H} NMR (202 MHz,
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acetone-d6, 298 K) δ/ ppm −11.0 (POP), −144.2 (septet, JPF = 708 Hz, PF6−). ESI-MS positive mode m/z
938.98 [M − PF6]+ (calc. 938.98), 601.11 [Cu(POP)]+ (calc. 601.09). Found: C 50.67, H 3.26, N 2.59;
C48H34Br2CuF6N2OP3·CH2Cl2 requires C 50.26, H 3.18, N 2.39.
3.6. [Cu(xantphos)(2,9-Br2phen)][PF6]
The reagents were [Cu(CH3CN)4][PF6] (66.3 mg, 0.18 mmol), 2,9-Br2phen (60 mg, 0.18 mmol)
and xantphos (113 mg, 0.20 mmol). [Cu(xantphos)(2,9-Br2phen)][PF6] was isolated as a yellow solid
(100 mg, 88.8 µmol, 50%). 1H NMR (500 MHz, acetone-d6) δ/ ppm 8.61 (d, J = 8.4 Hz, 2H, HA4), 8.14 (s,
2H, HA5), 8.06 (d, J = 8.4 Hz, 2H, HA3), 7.83 (d, J = 7.6 Hz, 2H, HC5), 7.34–7.24 (m, 14H, HD2+D4+C4),
7.16–7.08 (m, 10H, HD3+C3), 1.74 (s, 6H, HMe). 13C{1H} NMR (126 MHz, acetone-d6) δ/ ppm 155.8 (CC1),
143.8/143.2 (CA2+A10a), 141.2 (CA4), 134.3 (CC6), 134.1 (t, JPC = 7.6 Hz, CD2), 132.1 (t, JPC = 16.84 Hz,
CD1), 131.1 (CC3), 130.9 (CA3+D4), 129.8 (CA4a), 129.4 (t, JPC = 4.6 Hz, CD3), 128.8 (CC5), 128.1 (CA5), 126.0
(CC4), 122.6 (CC2), 36.6 (Cxantphos bridge), 29.2 (CCMe). 31P{1H} NMR (202 MHz, acetone-d6, 298 K) δ/ ppm
−12.2 (xantphos), −144.2 (septet, JPF = 707 Hz, PF6−). ESI-MS positive mode m/z 979.03 [M − PF6]+ (calc.
979.01), 641.13 [Cu(xantphos)]+ (calc. 641.12). Found: C 54.06, H 3.56, N 2.62; C51H38Br2CuF6N2OP3
requires C 54.44, H 3.40, N 2.49.
3.7. [Cu(xantphos)(3,8-Br2phen)][PF6]
The reagents were [Cu(CH3CN)4][PF6] (188 mg, 0.50 mmol), 3,8-Br2phen (170 mg, 0.50 mmol)
and xantphos (173 mg, 0.51 mmol). [Cu(xantphos)(3,8-Br2phen)][PF6] was isolated as orange solid
(496 mg, 0.44 mmol, 87%). 1H NMR (500 MHz, acetone-d6) δ/ ppm 8.99 (d, J = 2.0 Hz, 2H, HA4), 8.55
(m, 2H, HA2), 8.25 (s, 2H, HA5), 7.95 (dd, J = 7.9 Hz, 1.3 Hz, 2H, HC5), 7.34–7.27 (m, 6H, HD4+C4),
7.14 (m, 8H, HD3), 7.06 (m, 8H, HD2), 6.66 (m, 2H, HC3), 1.87 (s, 6H, HMe). 13C{1H} NMR (126 MHz,
acetone-d6) δ/ ppm 155.9 (CC1), 151.3 (CA2), 142.4 (CA10a), 140.6 (CA4), 135.0 (CC6), 133.8 (t, JPc = 8.0 Hz,
CD2), 132.2 (CC3), 131.8 (CD1), 131.6 (CA4a), 131.0 (CD4), 129.7 (t, JPc = 4.8 Hz, CD3), 128.9 (CA5+C5), 126.4
(CC4), 121.7 (CA3), 120.2 (CC2), 37.1 (Cxantphos bridge), 28.7 (CCMe). 31P{1H} NMR (202 MHz, acetone-d6),
298 K) δ/ ppm −11.0 (xantphos), −144.2 (septet, JPF = 707 Hz, PF6−). ESI-MS positive mode m/z 979.00
[M − PF6]+ (calc. 979.01), 641.12 [Cu(xantphos)]+ (calc. 641.12). Found: C 54.28, H 3.55, N 2.49;
C51H38Br2CuF6N2OP3 requires C 54.44, H 3.40, N 2.49.
3.8. [Cu(xantphos)(4,7-Br2phen)][PF6]
The reagents were [Cu(CH3CN)4][PF6] (64.9 mg, 0.17 mmol), 4,7-Br2phen (58.8 mg, 0.17 mmol)
and xantphos (111 mg, 0.19 mmol). [Cu(xantphos)(4,7-Br2phen)][PF6] was isolated as an orange solid
(150 mg, 133 µmol, 77%). 1H NMR (500 MHz, acetone-d6) δ/ppm 8.60 (d, J = 5.2 Hz, 2H, HA2), 8.50 (s,
2H, HA5), 8.22 (d, J = 5.0 Hz, 2H, HA3), 7.90 (dd, J = 7.8 Hz, 1.2 Hz, 2H, HC5), 7.33–7.26 (m, 6H, HD4+C4),
7.14 (m, 8H, HD3), 7.05 (m, 8H, HD2), 6.74 (m, 2H, HC3), 1.81 (s, 6H, HMe). 13C{1H} NMR (126 MHz,
acetone-d6) δ/ppm 155.8 (CC1), 150.7 (CA2), 144.8 (CA10a), 136.4/130.7 (CA4+A4a), 135.1 (CC6), 133.6 (t,
JPC = 8.0 Hz, CD2), 132.2 (CD1), 132.1 (CC3), 131.0 (CD4), 130.4 (CA3), 129.6 (t, JPC = 4.7 Hz, CD3), 128.9
(CC5), 127.9 (CA5), 126.2 (CC4), 120.3 (CC2), 37.1 (Cxantphos bridge), 28.7 (CCMe). 31P{1H} NMR (202 MHz,
acetone-d6, 298 K) δ/ppm −12.4 (xantphos), −144.3 (septet, JPF = 707 Hz, PF6−). ESI-MS positive mode
m/z 979.03 [M − PF6]+ (calc. 979.01), 641.15 [Cu(xantphos)]+ (calc. 641.12). Found: C 54.28, H 3.55,
N 2.49; C51H38Br2CuF6N2OP3 requires C 54.44, H 3.40, N 2.49.
3.9. Crystallography
Single crystal data were collected on a Bruker APEX-II diffractometer (Cu Kα radiation) with
data reduction, solution and refinement using the programs APEX [36], ShelXT [37], Olex2 [38] and
SHELXL v. 2014/7 [39], or using a STOE StadiVari diffractometer equipped with a Pilatus300K detector
and with a Metaljet D2 source (Ga Kα radiation); the structure was solved using Superflip [40,41] and
Olex2 [38]. See Sections 3.10–3.15 for details of the radiation type for each structure. The model was
refined with SHELXL v. 2014/7 [39]. Structure analysis used Mercury CSD v. 4.1.0 [42,43].
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For [Cu(POP)(4,7-Br2phen)][PF6].CH2Cl2, SQUEEZE [44] was used to treat the solvent region.
All the numbers and formulae were adapted to keep account of the fact that the electrons removed
equated to one molecule of CH2Cl2 per copper atom. SQUEEZE was also used to treat the solvent regions
in [Cu(xantphos)(4,7-Br2phen)][PF6]·CH2Cl2·0.9Et2O and [Cu(xantphos)(2,9-Br2phen)][PF6]·1.1CH2Cl2,
and all the numbers and formulae were adapted to account for this.
3.10. [Cu(POP)(2,9-Br2phen)][PF6]·0.5Et2O
C50H39Br2CuF6N2O1.5P3, Mr = 1122.10, yellow block, triclinic, space group P−1, a = 15.1949(10),
b = 18.5322(12), c = 18.5423(13) Å, α = 107.867(2), β = 104.444(2), γ = 101.088(2)◦, V = 4603.2(5) Å3, Dc
= 1.619 g cm–3, T = 130 K, Z = 4, Z’ = 2, µ(CuKα) = 4.260 mm−1. Total 38,972 reflections, 16,488 unique
(Rint = 0.0241). Refinement of 15,466 reflections (1182 parameters) with I > 2σ(I) converged at final R1
= 0.0369 (R1 all data = 0.0389), wR2 = 0.0952 (wR2 all data = 0.0971), gof = 1.028. CCDC 1966898.
3.11. [Cu(POP)(3,8-Br2phen)][PF6]·0.8CH2Cl2·0.9H2O
C48.8H37.4Br2Cl1.6CuF6N2O1.9P3, Mr = 1169.20, yellow plate, monoclinic, space group P2/c, a =
12.9120(7), b = 14.0896(8), c = 27.1332(13) Å, β = 94.491(2)◦, V = 4921.0(5) Å3, Dc = 1.578 g cm−3,
T = 130 K, Z = 4, Z’ = 1, µ(CuKα) = 4.797 mm−1. Total 30,196 reflections, 8930 unique (Rint = 0.0313).
Refinement of 8307 reflections (556 parameters) with I > 2σ(I) converged at final R1 = 0.0870 (R1 all
data = 0.0905), wR2 = 0.2489 (wR2 all data = 0.2516), gof = 1.124. CCDC 1966896.
3.12. [Cu(POP)(4,7-Br2phen)][PF6]·CH2Cl2
C49H36Br2Cl2CuF6N2OP3, Mr = 1169.97, yellow block, triclinic, space group P−1, a = 12.4032(9),
b = 18.9805(14), c = 22.0591(17) Å, α = 70.330(3), β = 77.791(3), γ = 87.292(3)◦, V = 4777.9(6) Å3, Dc =
1.626 g cm−3, T = 130 K, Z = 4, Z’ = 2, µ(CuKα) = 5.128 mm−1. Total 42,627 reflections, 17,481 unique
(Rint = 0.0261). Refinement of 16,297 reflections (1135 parameters) with I > 2σ(I) converged at final R1
= 0.0327 (R1 all data = 0.0350), wR2 = 0.0817 (wR2 all data = 0.0834), gof = 1.011. CCDC 1966899.
3.13. [Cu(xantphos)(2,9-Br2phen)][PF6]·1.1CH2Cl2
C52.1H40.2Br2Cl2.2CuF6N2OP3, Mr = 1218.52, yellow plate, monoclinic, space group C2/m, a =
33.3182(16), b = 14.1050(6), c = 11.8205(5) Å, β = 102.059(5)◦, V = 5432.5(4) Å3, Dc = 1.490 g cm−3,
T = 130 K, Z = 4, Z’ = 0.5, µ(GaKα) = 4.895 mm−1. Total 15,005 reflections, 5607 unique (Rint = 0.0515).
Refinement of 4802 reflections (417 parameters) with I > 2σ(I) converged at final R1 = 0.0728 (R1 all
data = 0.0863), wR2 = 0.1853 (wR2 all data = 0.1973), gof = 1.034. CCDC 1966895.
3.14. [Cu(xantphos)(3,8-Br2phen)][PF6]·1.1CH2Cl2·0.7Et2O
C54.9H47.2Br2Cl2.2CuF6N2O1.7P3, Mr = 1270.40, yellow block, triclinic, space group P−1, a =
10.1768(8), b = 13.7504(11), c = 20.1505(16) Å, α = 90.204(2), β = 98.120(2), γ = 99.535(2)◦, V = 2751.9(4)
Å3, Dc = 1.533 g cm−3, T = 130 K, Z = 2, Z’ = 1, µ(CuKα) = 4.597 mm−1. Total 35,742 reflections, 10,241
unique (Rint = 0.0264). Refinement of 9939 reflections (728 parameters) with I > 2σ(I) converged at final
R1 = 0.0382 (R1 all data = 0.0391), wR2 = 0.1093 (wR2 all data = 0.1101), gof = 1.073. CCDC 1966894.
3.15. [Cu(xantphos)(4,7-Br2phen)][PF6]·CH2Cl2·0.9Et2O
C55.6H49Br2Cl2CuF6N2O1.9P3, Mr = 1276.74, yellow block, triclinic, space groupP−1, a= 10.9300(4),
b = 14.2927(6), c = 19.2894(8) Å, α = 70.366(3), β = 86.491(3), γ = 73.206(3)◦, V = 2715.0(2) Å3, Dc =
1.562 g cm−3, T = 130 K, Z = 2, Z’ = 1, µ(GaKα) = 4.864 mm−1. Total 32,020 reflections, 10,645 unique
(Rint = 0.0795). Refinement of 9958 reflections (624 parameters) with I > 2σ(I) converged at final R1 =
0.0858 (R1 all data = 0.0904), wR2 = 0.2317 (wR2 all data = 0.2384), gof = 1.059. CCDC 1966897.
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4. Conclusions
We prepared and characterized a series of [Cu(POP)(Br2phen)][PF6] and [Cu(xantphos)(Br2phen)]
[PF6] compounds in which Br2phen represents the isomers 2,9-Br2phen, 3,8-Br2phen and 4,7-Br2phen.
The formation of these heteroleptic compounds was confirmed by mass spectrometry and single-crystal
X-ray structures. The solution 1H, 13C{1H} and 31P{1H} NMR spectra of the copper(I) complexes
are consistent with the retention of the structures in solution. Each compound undergoes
a partially reversible or irreversible copper-centred oxidation, the highest potential being for
2,9-Br2phen-containing compounds, consistent with bromo-substituents in the 2,9-positions hindering
flattening of the copper(I) coordination sphere on oxidation. In solution, the compounds are weak
yellow or orange emitters, and values of λemmax = 596 and 582 nm for [Cu(POP)(2,9-Br2phen)][PF6]
and [Cu(xantphos)(2,9-Br2phen)][PF6] are blue-shifted with respect to those for the complexes
containing 3,8-Br2phen and 4,7-Br2phen (λemmax in the range 653 to 660 nm). In the solid state,
all six [Cu(POP)(Br2phen)][PF6] and [Cu(xantphos)(Br2phen)][PF6] complexes are yellow or orange
emitters (λemmax in the range 554 to 604 nm), the highest-energy being the 2,9-Br2phen-containing
complexes. The highest PLQY (45%) is observed for [Cu(xantphos)(2,9-Br2phen)][PF6] (τ1/2 = 9.9 µs).
Comparisons of the photophysical properties with those of analogous compounds containing phen or
2,9-Me2phen indicate that the incorporation of the bromo-substituents in the 2,9-positions is not as
beneficial as the presence of methyl groups.
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